Skip to content

An investigation on the efficacy, mechanism and evaluation system of electroacupuncture in the treatment of patient with mild cognitive impairment due to Alzheimer's disease

An investigation on the efficacy, mechanism and evaluation system of electroacupuncture in the treatment of patient with mild cognitive impairment due to Alzheimer's disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079668
Enrollment
Unknown
Registered
2024-01-09
Start date
2023-05-01
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer’s disease

Interventions

sham electroacupuncture group:sham electroacupuncture

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: ? The patients met the diagnostic criteria of AD-induced MCI issued by the National Institute on Aging and Alzheimer's disease (NIA-AA) in 2011. (2) patients complained of cognitive changes, or reported by caregivers or clinicians; (3) one or more cognitive domains were impaired, including memory, executive function, attention, language and visuospatial function, especially episodic memory. ? Auditory speech learning test (AVLT) showed that the patient had objective memory decline. ? The MoCA score was less than 26, and the CDR score was 0.5. ? MMSE score was more than 20. ? They had independent activities of daily living, no evidence of serious influence on social or occupational function, and their ADL score was less than 26. ? Willing and able to complete all the content of this study, including neuropsychological assessment and blood collection Relevant indicators, electrophysiological and neuroimaging examinations were performed, and longitudinal follow-up was agreed. ? Agree to sign the informed consent form.

Exclusion criteria

Exclusion criteria: ? The presence of a history of stroke temporally related to the onset or worsening of cognitive impairment, or the presence of multiple or extensive cerebral infarction or severe white matter hyperintensities; ? with the core features of Lewy body disease; ? with the significant characteristics of behavioral variant frontotemporal lobar degeneration. (4) significant features of primary progressive semantic aphasia or primary progressive nonfluent/grammatical aphasia. And 5) there were other evidence that significantly affected cognitive function, such as neurological diseases, non-neurological diseases or drug abuse history. ? Dysarthria, depression and mental illness affect emotional expression. ? Patients with contraindications of magnetic resonance imaging, visual and hearing impairment could not cooperate to complete all examination items. ? There is a bleeding tendency such as thrombocytopenia and abnormal coagulation function, or any disease that cannot be treated with acupuncture and intervention.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment, MoCA;

Secondary

MeasureTime frame
Clinical Dementia Rating,CDR;Mini-Mental State Examination, MMSE;Alzheimer’s Disease Assessment Scale-Cognitive Subscale,ADAS-cog;Auditory Verb Learning Test,AVLT;Rey Complex Figure Test-Delay Recall, RCFT-DR;Rey Complex Figure Test, RCFT;Clock drawing test, CDT; Animal Fluency Test, AFT;Boston Naming Test, BNT;Chinese Modified Version of the Trail Making Test-A, TMT-A; Chinese Modified Version of the Trail Making Test-B, TMT-B;Neuropsychiatric Inventory,NPI;Hamilton Rating Scale for Depression,HAMD;Hamilton Anxiety Rating Scale,HAMA;Pittsburgh sleep quality index, PSQI;Cohen-Mansfield Agitation Inventory, CMAI;Modified Apathy Evaluation Scale,MAES;Activities of Daily Living, ADL;AD neuropathological proteins;Neuroimmune inflammatory factors;neurotrophin;neurotransmitter; event-related potential P300; rs-fMRI;

Countries

China

Contacts

Public ContactWei Zhang

Beijing Tiantan Hospital, Capital Medical University

ttyyzw@163.com+86 139 1199 6107

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026